Assays for Fibrinogen and Its Derivatives

References

• Davie E. W., Schmer G. Modern concept of blood coagulation. Coagulation, Current Research and Clinical Applications, G. Schmer, P. E. Strandjord. Academic Press, New York 1973; 3
   Google Scholar
• Weiss H. J. Platelet physiology and abnormalities of platelet function. New Engl. J. Med. 1975; 293: 531
   PubMed Web of Science ®Google Scholar
• Weinstein M. J., Doolittle R. F. Differential specificities of thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors. Biochim. Biophys. Acta 1972; 258: 577
   PubMedGoogle Scholar
• Astrup T. Blood coagulation and fibrinolysis in tissue culture and tissue repair. Biochem. Pharmacol. Suppl. 1968; 241
   PubMedGoogle Scholar
• Todd A. S. Localization of fibrinolytic activity in tissues. Br. Med. Bull. 1964; 20: 210
   PubMed Web of Science ®Google Scholar
• Kwaan H. C., Astrup T. Fibrinolytic activity of reparative connective tissue. J. Pathol. Bacteriol. 1964; 87: 409
   PubMedGoogle Scholar
• Pizzo S. V., Schwartz M. L., Hill R. L., McKee P. A. The effect of plasmin on the subunit structure of human fibrinogen. J. Biol. Chem. 1972; 247: 636
   PubMed Web of Science ®Google Scholar
• Marder V. J., Budzynski A. Z., James H. L. High molecular weight derivatives of human fibrinogen produced by plasmin. J. Biol. Chem. 1972; 247: 4775
   PubMed Web of Science ®Google Scholar
• Pizzo S. V., Taylor L. M., Slade C. L., Schwartz M. L., Hill R. L., McKee P. A. The subunit structure of plasmin degraded human fibrinogen, noncross-linked, partially cross-linked and fully cross-linked fibrin. in 3rd Congr., International Society for Thrombosis and Haemostasis (Abstract), Washington, D.C., 1972; 304
   Google Scholar
• Dudek G. A., Klaczewiak M., Budzynski A. Z., Latallo Z. S., Kopec M. Characterization and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin. Biochim. Biophys. Acta 1970; 214: 44
   PubMedGoogle Scholar
• Niewiarowski S., Nandi M. Acrylamide gel electrophoresis of fibrinogen and fibrin degradation products. Br. J. Haematol. 1971; 21: 71
   PubMedGoogle Scholar
• Gaffney P. J. Molecular aspects of fibrin clot solubilization. Nat. New Biol. 1971; 234: 281
   PubMedGoogle Scholar
• Marder V. J., Budzynski A. Z. Degradation products of fibrinogen and cross-linked fibrin - projected clinical applications. Thromb. Diath. Haemorrh. 1974; 32: 49
   PubMedGoogle Scholar
• Catanzaro A., Edgington T. S. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plamin. J. Lab. Clin. Med. 1974; 83: 458
   PubMedGoogle Scholar
• Gans H., Subramanian V., Tan B. H. Selective phagocytosis: a new concept in protein catabolism. Science 1968; 159: 107
   Google Scholar
• Walsh R. T., Barnhart M. I. Clearance of coagulation and fibrinolysis products by the reticuloendothelial system. Thromb. Diath. Haemorrh. Suppl. 1969; 36(Suppl. 29)83
   PubMedGoogle Scholar
• Rayner H., Paraskevas F., Israels L. G., Israels E. D. Fibrinogen breakdown products: identification and assay in serum and urine. J. Lab. Clin. Med. 1969; 74: 586
   PubMed Web of Science ®Google Scholar
• Sharma L. A., Harwig S., Lee J. In vitro formation and in vivo clearance of fibrinogen: fibrin complexes. J. Lab. Clin. Med. 1975; 86: 100
   PubMedGoogle Scholar
• Riddle J. M., Barnhart M. I. Ultrastructural study of fibrin dissolution via emigrated polymorphonuclear leukocytes. Am. J. Pathol. 1964; 45: 805
   PubMedGoogle Scholar
• Barnhart M. I. Importance of neutrophilic leukocytes in the resolution of fibrin. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1965; 24: 846
   PubMedGoogle Scholar
• Hall C. E. Electron microscopy of fibrinogen and fibrin. J. Biol. Chem. 1949; 179: 857
   PubMed Web of Science ®Google Scholar
• Hall C. E., Slayter H. S. The fibrinogen molecule: its size, shape and mode of polymerization. J. Biophys. Biochem. Cytol. 1959; 5: 11
   PubMedGoogle Scholar
• Doolittle R. F. Structural aspects of the fibrinogen to firbrin conversion. Advances in Protein Chemistry, C. B. Anfinsen, J. T. Edsall, F. M. Richards. Academic Press, New York 1973; Vol. 27: 1
   Google Scholar
• Wintrobe M. M. Clinical Hematology, 6th ed., M. M. Wintrobe, et al. Lea & Febiger, Philadelphia 1967; 355
   Google Scholar
• Davidsohn I., Nelson D. A. The blood. Clinical Diagnosis by Laboratory Methods, 15th ed., I. Davidsohn, B. J. Henry. W. B. Saunders, Philadelphia 1974; 133
   Google Scholar
• Huseby R. M., Bang N. U. Fibrinogen. Thrombosis and Bleeding Disorders, N. U. Bang, F. K. Beller, E. Deutsch, E. F. Mammen. Academic Press, New York 1971; 226
   Google Scholar
• Smith G. F., Bang N. U. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer. Biochemistry 1972; 11: 2958
   PubMed Web of Science ®Google Scholar
• Ferry J. D., Morrison P. R. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J. Am. Chem. Soc. 1947; 69: 388
   PubMed Web of Science ®Google Scholar
• Morrison P. R. Preparation and properties of serum and plasma proteins. XV. Some factors influencing the quantitative determination of fibrinogen. J. Am. Chem. Soc. 1947; 69: 2723
   PubMedGoogle Scholar
• Bang N. U. Ultrastructure of the fibrin clot. Blood Clotting Enzymology, W. H. Seegers. Academic Press, New York 1967; 495
   Google Scholar
• Davie E. W., Fujikawa K. Basic mechanisms in blood coagulation. Annu. Rev. Biochem. 1975; 44: 799
   PubMed Web of Science ®Google Scholar
• Ratnoff O. D., Lauster C. F., Sholl J. G., Schilling M. O. A hemorrhagic state during pregnancy. Am. J. Med. 1952; 13: 111
   PubMedGoogle Scholar
• Shaw S. T., Jr., Aaronson D. E., Kuyumjian N., unpublished observations
   Google Scholar
• McDonagh J., Wagner R. H. Site of synthesis of plasma and platelet factor XIII. Ann. N.Y. Acad. Sci. 1972; 202: 31
   PubMedGoogle Scholar
• McDonagh R. P., Jr., McDonagh J., Blombäck B. Polypeptide chains of human fibrin: Molecular organization and cross-linking. Ann. N.Y. Acad. Sci. 1972; 202: 335
   PubMedGoogle Scholar
• Stewart G. J. An electron microscope study of the polymerization of fibrinogen and its derivatives. Scand. J. Haematol. Suppl. 1971; 13: 165
   PubMedGoogle Scholar
• Stewart D. J., Niewiarowski S. Nonenzymatic polymerization of fibrinogen by protamine sulfate. Biochim. Biophys. Acta 1969; 194: 462
   PubMedGoogle Scholar
• Latallo Z. S., Wegrzynowicz Z., Budzynski A. Z., Kopec M. Effect of protamine sulphate on the solubility of fibrinogen, its derivatives and other plasma proteins. Scand. J. Haematol. Suppl. 1971; 13: 151
   PubMedGoogle Scholar
• Laki K., Benko A., Farrel J. Clot stabilization and atherosclerosis. Ann. N.Y. Acad. Sci. 1972; 202: 235
   PubMedGoogle Scholar
• Kanaide H., Braun W. E., Shainoff J. R. “Macrofibrinogen”. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1973; 32: 835
   Google Scholar
• Kanaide H., Shainoff J. R. Crossing-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J. Lab. Clin. Med. 1975; 85: 574
   PubMedGoogle Scholar
• Cohn E. J., Strong L. E., Hughes W. L., Jr., Mulford D. J., Ashworth J. N., Melin M., Taylor H. L. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 1946; 68: 459
   PubMed Web of Science ®Google Scholar
• Miller L. L., Bly C. G., Watson M. L., Bale W. F. The dominant role of the liver in plasma protein synthesis. J. Exp. Med. 1951; 94: 431
   PubMed Web of Science ®Google Scholar
• Straub P. W. A study of fibrinogen production by human liver slices in vitro by an immunoprecipitin method. J. Clin. Invest. 1963; 42: 130
   PubMed Web of Science ®Google Scholar
• Barnhart M. I., Anderson G. F. Intracellular localization of fibrinogen. Proc. Soc. Exp. Biol. Med. 1962; 110: 734
   PubMedGoogle Scholar
• Forman W. B., Barnhart M. I. Cellular site for fibrinogen synthesis. JAMA 1964; 187: 128
   PubMed Web of Science ®Google Scholar
• Miller L. L., Titthasiria N., Hanvan H. R., Adelson E. Fibrinogen and fibrin - Normal metabolism. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1965; 24: 810, cited by
   PubMedGoogle Scholar
• Barnhart M. I., Cress D. C., Noonan S. M., Walsh R. T. Influence of fibrinolytic products on hepatic release and synthesis of fibrinogen. Thromb. Diath. Haemorrh. Suppl. 1970; 39: 143
   Google Scholar
• Bonnar J., McNicol G. P., Douglas A. S. Coagulation defects in obstetrics. Modern Trends in Obstetrics, R. J. Kellar. Butterworths, London 1969
   Google Scholar
• Medhat I. A., Toppozada H. K., Rizk M. A., Khowessah M. M., Abdel Malek A. T. A study of the effect of an oral contraceptive on blood coagulation factors, platelets, and fibrinolytic activity. Contraception 1974; 9: 379
   PubMedGoogle Scholar
• Adelson E. Fibrinogen and fibrin - Normal metabolism. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1965; 24: 810
   PubMedGoogle Scholar
• Bickford A. F., Sokolow M. Fibrinolysis as related to the urea solubility of fibrin. Thromb. Diath. Haemorrh. 1961; 5: 480
   Google Scholar
• Gormsen J., Fletcher A. P., Alkjaersig N., Sherry S. Enzymic lysis of plasma clots: the influence of fibrin stabilization on lysis rates. Arch. Biochem. Biophys. 1967; 120: 654
   Google Scholar
• Rabiner S. F., Robbins K. C. Studies on fibrinolysis. I. A circulating substance capable of converting plasmin-sensitive to plasmin-resistant clots. Proc. Soc. Exp. Biol. Med. 1962; 111: 701
   PubMedGoogle Scholar
• Gallimore M. J., Tyler H. M., Shaw J. T. B. The origin of fibrin breakdown products and the interpretation of their appearance in the circulation. J. Clin. Pathol. 1972; 25: 185
   PubMedGoogle Scholar
• Cash J. D. Physiological aspects of fibrinolysis. Synthetic Fibrinolytic, Thrombolytic Agents, K. N. von Kaulla, J. F. Davidson. Charles C Thomas, Springfield, III. 1975; 5
   Google Scholar
• Marder V. J. Discussion section 1–6, Fibrinogen degradation products. Scand. J. Haematol. Suppl. 1971; 13: 64
   Google Scholar
• Kowalski E. Fibrinogen derivatives and their biologic activities. Semin. Hematol. 1968; 5: 45
   Google Scholar
• Malofiejew M. The biological and pharmacological properties of some fibrinogen degradation products. Scand. J. Haematol. Suppl. 1971; 13: 303
   PubMedGoogle Scholar
• Barnhart M. I., Sulisz L., Bluhm G. B. Role for fibrinogen and its derivatives in acute inflammation. Immunopathology of Inflammation, B. K. Forscher, J. C. Houck. Excerpta Medica, Amsterdam 1971; 59
   Google Scholar
• Larrieu M. J. Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation. Scand. J. Haematol. Suppl. 1971; 13: 273
   PubMedGoogle Scholar
• de Gaetano G., Donati M. B., Vermylen J. Human platelet clumping by bovine fibrinogen during its degradation. Scand. J. Haematol. Suppl. 1971; 13: 281
   PubMedGoogle Scholar
• Salmon J. Inhibition of thrombocytopenia of immunological origin by fibrinogen degradation products. Scand. J. Haematol. Suppl. 1971; 13: 285
   PubMedGoogle Scholar
• Stecher V. J., Sorkin E. The chemotactic activity of fibrin lysis products. Int. Arch. Allergy 1972; 43: 879
   Google Scholar
• Richardson D. L., Pepper D. S., Kay A. B. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br. J. Haematol. 1976; 32: 507
   PubMed Web of Science ®Google Scholar
• Bang H. O. Quantitative determination of fibrinogen in plasma - Gram's method modified. Scand. J. Clin. Lab. Invest. 1957; 9: 205
   PubMed Web of Science ®Google Scholar
• Ham T. H., Curtis F. C. Plasma fibrinogen response to man. Medicine 1938; 17: 413
   Google Scholar
• Parfentjev I. A., Johnson M. L., Cliffton E. E. The determination of plasma fibrinogen by turbidity with ammonium sulfate. Arch. Biochem. 1953; 46: 470
   PubMed Web of Science ®Google Scholar
• Persson I. Normal values for plasma fibrin in the age group 20–50 years. Scand. J. Clin. Lab. Invest. 1953; 7: 279
   Google Scholar
• Ratnoff O. D., Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. Clin. Med. 1951; 37: 316
   PubMed Web of Science ®Google Scholar
• Reiner M., Cheung H. L. Fibrinogen. Standard Methods of Clinical Chemistry, D. Seligson. Academic Press, New York 1961; Vol. 3: 114
   Google Scholar
• Saifer A., Newhouse A. Photometric microdetermination of plasma fibrinogen with a thrombin-ninhydrin procedure. J. Biol. Chem. 1954; 208: 159
   PubMedGoogle Scholar
• Trevorrow V., Kaser M., Patterson J. P., Hill R. M. Plasma albumin, globulin, and fibrinogen in healthy individuals from birth to adulthood. J. Lab. Clin. Med. 1942; 27: 471
   Google Scholar
• Ogston C. M., Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J. Clin. Pathol. 1966; 19: 352
   PubMed Web of Science ®Google Scholar
• Crane M. M., Sanford H. N. Substances involved in the coagulation of the blood of the new-born infant. Am. J. Dis. Child. 1936; 51: 99
   Google Scholar
• Hathaway W. E. The bleeding newborn. Semin. Hematol. 1975; 12: 175
   PubMedGoogle Scholar
• Grannis G. F. Plasma fibrinogen, determination, normal values, physiopathologic shifts, and fluctuations. Clin. Chem. 1970; 16: 486
   PubMed Web of Science ®Google Scholar
• Brakman P., Albrechtsen O. K., Astrup T. A comparative study of coagulation and fibrinolysis in blood from normal men and women. Br. J. Haematol. 1966; 12: 74
   PubMed Web of Science ®Google Scholar
• Das P. C., Allan A. G. E., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br. Med. J. 1967; 4: 718
   PubMedGoogle Scholar
• Cash J. D. Effect of moderate exercise on the fibrinolytic system in normal young men and women. Br. Med. J. 1966; 2: 502
   PubMedGoogle Scholar
• Basu H. K. Fibrin degradation products in sera of women with normal menstruation and menorrhagia. Br. Med. J. 1970; 1: 74
   PubMedGoogle Scholar
• Woodfield D. G., Cole S. K., Allan A. G. E., Cash J. D. Serum fibrin degradation products throughout normal pregnancy. Br. Med. J. 1968; 4: 665
   PubMedGoogle Scholar
• Beller F. K., Nachtigall L., Rosenberg M. Coagulation studies of menopausal women taking estrogen replacement. Obstet. Gynecol. 1972; 39: 775
   PubMedGoogle Scholar
• Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br. Med. J. 1969; 3: 137
   PubMed Web of Science ®Google Scholar
• Owen C. A., Bowie E. J. W., Didisheim P., Thompson J. H. Inherited hemorrhagic diseases. The Diagnosis of Bleeding Disorders. Little, Brown, Boston 1969; 113
   Google Scholar
• Rizza C. R. Clotting factor deficiencies. Human Blood Coagulation, Hemostasis and Thrombosis, R. Biggs. Blackwell, Oxford 1972; 212
   Google Scholar
• Blombäck M., Blombäck B., Mammen E. F., Prasad A. S. Fibrinogen Detroit - a molecular defect in the N-terminal disulphide knot of human fibrinogen?. Nature 1968; 218: 134
   PubMed Web of Science ®Google Scholar
• Denson K. W. E. Abnormal clotting factors. Human Blood Coagulation, Hemostasis and Thrombosis, R. Biggs. Blackwell, Oxford 1972; 202
   Google Scholar
• Menache D. Abnormal fibrinogens, a review. Thromb. Diath. Haemorrh. 1973; 29: 525
   PubMedGoogle Scholar
• Al-Mondhiry H. A. B., Bilezikian S. B., Nossel H. L. Fibrinogen “New York” - An abnormal fibrinogen associated with thromboembolism: functional evaluation. Blood 1975; 45: 607
   PubMedGoogle Scholar
• Samori T., Yatabe M., Ukita M., Fujimoki M., Fukutaki K. A new type of congenital dsyfibrinogenemia (Fibrinogen Tokyo) with defective stabilization of fibrin polymers. Thromb. Diath. Haemorrh. 1975; 34: 329
   PubMedGoogle Scholar
• Budzynski A. Z., Marder V. J., Menache D., Guillin M. C. Structural abnormality in the gamma polypeptide chain of Paris 1 fibrinogen. Thromb. Diath. Haemorrh. 1975; 34: 329
   PubMedGoogle Scholar
• Morse E. E. Fibrinogen and the fibrinogenopathies. Ann. Clin. Lab. Sci. 1971; 1: 155
   PubMedGoogle Scholar
• Ratnoff O. D., Forman W. B. Criteria for the differentiation of dysfibrinogenemic states. Semin. Hematol. 1976; 13: 141
   PubMedGoogle Scholar
• Barr R. D., Ouna N., Simpson J. G., Bagshawe A. F. Dysfibrinogenemia and primary hepatocellular carcinoma. Q. J. Med. New Ser. 1976; 45: 647
   PubMedGoogle Scholar
• Green G., Thomson J. M., Dymock I. W., Poller L. Abnormal fibrin polymerization in liver disease. Br. J. Haematol. 1976; 34: 427
   PubMedGoogle Scholar
• Cotran R. S. Studies on inflammation - ultrastructure of the prolonged vascular response induced by Clostridium oedematiens toxin. Lab. Invest. 1967; 17: 39
   PubMedGoogle Scholar
• Majno G., Palade G. E. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J. Biophys. Biochem. Cytol. 1961; 11: 571
   PubMedGoogle Scholar
• Rodman N. F. Thrombosis. The Inflammatory Process, B. W. Zweifach, L. Grant, R. T. McCluskey. Academic Press, New York 1974; Vol. 2: 364
   Google Scholar
• Baker L. R. I., Rubenberg M. L., Dacie J. V., Brain M. C. Fibrinogen catabolism in microangiopathic haemolytic anemia. Br. J. Haematol. 1968; 14: 617
   PubMed Web of Science ®Google Scholar
• Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N. Engl. J. Med. 1972; 287: 999
   PubMed Web of Science ®Google Scholar
• F. D. P. Lancet 1972; 2: 957
   PubMedGoogle Scholar
• Shah B. C., Ambrus J. L., Mink I. B., Albert D. J., Sampson D., Murphy G. P. Fibrin degradation products in renal parenchymal disease states and renal translant patients. Transplantation 1972; 14: 705
   PubMedGoogle Scholar
• Ambrus J. L., Baliah H. T., Ambrus C. M., Mink I. B., Murphy G. P. Fibrin-fibrinogen degradation products in children with renal disease. N. Y. State J. Med. 1974; 74: 1396
   PubMedGoogle Scholar
• Wardle E. N. Serum and urine F.R.-antigen in renal disease. Br. Med. J. 1972; 4: 427
   PubMedGoogle Scholar
• Uttley W. S., Maxwell H., Cash J. D. Fibrin/fibrinogen degradation products in children with renal disease. Arch. Dis. Child. 1974; 49: 137
   PubMedGoogle Scholar
• Marchesis S. L., Aptekar R. G., Steinberg A. D., Gralnick H. R., Decker J. L. Urinary fibrin split products in lupus nephritis. Arthritis Rheum. 1974; 17: 158
   PubMedGoogle Scholar
• Hoq M. S., Clarkson A. R., Anderton J. L., Cash J. D. Urinary excretion heterophile (sheep) hemagglutinins and fibrin/fibrinogen degradation products after renal transplantation and in proliferative glomerulonephritis. Lancet 1973; 1: 1029
   PubMedGoogle Scholar
• Naish P., Evans D. J., Peters D. K. Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis. Br. Med. J. 1974; 1: 544
   PubMedGoogle Scholar
• Minna J. D., Robboy S. G., Colman R. W. Disseminated Intravascular Coagulation in Man. Charles C Thomas, Springfield, Ill. 1974, chap. 13
   Google Scholar
• Clark R. D., Gazzard B. G., Lewis M. L., Flute P. T., Williams R. Fibrinogen metabolism in acute hepatitis and active chronic hepatitis. Br. J. Haematol. 1975; 30: 95
   PubMed Web of Science ®Google Scholar
• Jim R. T. S. A study of the plasma thrombin time. J. Lab. Clin. Med. 1957; 50: 45
   PubMed Web of Science ®Google Scholar
• Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957; 17: 237
   PubMedGoogle Scholar
• Koepke J. A., Gilmer P. R., Filip D. J., Eckstein J. D., Sibley C. A. Studies of fibrinogen measurement in the CAP survey program. Am. J. Clin. Pathol. 1975; 63: 984
   PubMedGoogle Scholar
• Donati M. B., Vermylen J., Verstraete M. Fibrinogen degradation products and a fibrinogen assay based on clotting kinetics. Scand. J. Haematol. Suppl. 1971; 13: 255
   PubMedGoogle Scholar
• Vermylen C., DeVreker R. A., Verstraete M. A rapid enzymatic method for assay of fibrinogen-fibrin polymerization time (FPT test). Clin. Chim. Acta 1963; 8: 418
   PubMed Web of Science ®Google Scholar
• Natelson E. A., Dooley D. F. Rapid determination of fibrinogen by thrombokinetics. Am. J. Clin. Pathol. 1974; 61: 828
   PubMedGoogle Scholar
• Mason W. B., Henry R. J. Photometry and spectrophotometry. Clinical Chemistry: Principles and Techniques, 2nd ed., R. J. Henry, D. C. Cannon, J. W. Winkelman. Harper & Row, Hagerstown, Md 1974; 45
   Google Scholar
• Rafferty N. S., Tyrol A. G., Parfentjev I. A. Turbidimetric analysis of fibrinogen and gamma-globulin with ammonium sulfate by different photometric techniques. Clin. Chem. 1958; 4: 185
   PubMedGoogle Scholar
• Fowell A. H. Turbidimetric method of fibrinogen assay. Am. J. Clin. Pathol. 1955; 25: 340
   PubMedGoogle Scholar
• Hunter D. T., Allensworth J. L. A modified fibrinogen assay. Tech. Bull. Regist. Med. Technol. 1965; 35: 145
   PubMedGoogle Scholar
• Martinek R. G., Berry R. E. Micromethod for the estimation of plasma fibrinogen. Clin. Chem. 1965; 11: 10
   PubMedGoogle Scholar
• King E. J., Wootion I. D. P. Micromethods in Medical Biochemistry. Churchill, London 1956; 611
   Google Scholar
• Podmore D. A. Rapid turbidimetric methods for the determination of plasma fibrinogen. Clin. Chim. Acta 1959; 4: 242
   PubMedGoogle Scholar
• Campbell W. R., Hanna M. I. The albumin, globulins, and fibrogen of serum and plasma. J. Biol. Chem. 1937; 119: 15
   Google Scholar
• Goodwin J. F. An evaluation of technics for the separation and estimation of plasma fibrinogen. Clin. Chem. 1965; 11: 63
   PubMedGoogle Scholar
• Goodwin J. F. Microestimation of fibrinogen with a semimicro modification applicable to icteric plasma. Clin. Chem. 1967; 13: 947
   PubMedGoogle Scholar
• Howe P. E. The determination of fibrinogen by precipitation with sodium sulfate compared with the precipitation of fibrin by the action of calcium chloride. J. Biol. Chem. 1923; 57: 235
   Google Scholar
• Cullen G. E., Van Slyke D. D. Determination of the fibrin, globulin, and albumin nitrogen of blood serum. J. Biol. Chem. 1920; 41: 587
   Google Scholar
• Reinhold J. G. Total protein, albumin and globulin. Standard Methods of Clinical Chemistry, M. Reiner. Academic Press, New York 1953; Vol. 1: 88
   Google Scholar
• Friedman H. S. Gamma globulin in serum. Standard Methods of Clinical Chemistry, D. Seligson. Academic Press, New York 1958; Vol. 2: 40
   Google Scholar
• Wu H. A new colorimetric method for the determination of plasma proteins. J. Biol. Chem. 1922; 51: 33
   Google Scholar
• Wu H., Ling S. M. Colorimetric determination of proteins in plasma, cerebrospinal fluid and urine. Chin. J. Physiol. 1927; 1: 161
   Google Scholar
• Folin O., Ciocalteu V. Tyrosine and tryptophane determinations in proteins. J. Biol. Chem. 1927; 73: 627
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Daughaday W. H., Lowry O. H., Rosebrough N. J., Fields W. S. Determination of cerebrospinal fluid protein with the Folin phenol reagent. J. Lab. Clin. Med. 1952; 39: 663
   PubMed Web of Science ®Google Scholar
• Merskey C., Johnson A. J., Kleiner C. J., Wohl H. The defibrination syndrome: clinical features and laboratory diagnosis. Br. J. Haematol. 1967; 13: 528
   PubMed Web of Science ®Google Scholar
• Sharp A. A., Howie B., Biggs R., Methuen D. T. Defibrination syndrome in pregnancy - value of various diagnostic tests. Lancet 1958; 2: 1309
   PubMedGoogle Scholar
• Phillips L. L., Jenkins E. B., Hardaway R. M. Comparison of two methods for determination of fibrinogen. Tech. Bull. Regist. Med. Technol. 1969; 39: 130
   PubMedGoogle Scholar
• Stevens D. J., Sanfelippo M. J. Evaluation of three methods for plasma fibrinogen determination. Am. J. Clin. Pathol. 1973; 60: 182
   PubMedGoogle Scholar
• Flip D. J., Eckstein J. D., Sibley C. A. Observations on diagnostic kits for the determination of plasma fibrinogen. Am. J. Clin. Pathol. 1974; 62: 32
   PubMedGoogle Scholar
• Roberts P. S., Regelson W., Kingsbury B. Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants. J. Lab. Clin. Med. 1973; 82: 822
   PubMedGoogle Scholar
• Gitlin D., Borges W. H. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood 1953; 8: 679
   PubMed Web of Science ®Google Scholar
• Fox F. J., Wide L., Killander J., Gemzell C. Determination of fibrinogen and fibrinolysis products in human plasma by an immunochemical method. Scand. J. Clin. Lab. Invest. 1965; 17: 341
   PubMed Web of Science ®Google Scholar
• Brittin G. M., Rafinia H., Raval D., Werner M., Brown B. Evaluation of single radial immunodiffusion for quantitation of plasma fibrinogen. Am. J. Clin. Pathol. 1971; 57: 89
   Google Scholar
• Zucker M. B., Pert J. H., Hilgartner M. W. Platelet function in a patient with thrombasthenia. Blood 1966; 28: 524
   PubMed Web of Science ®Google Scholar
• Castelan D. J., Hirsh J., Martin M. Latex-bound antifibrinogen test for plasma fibrinogen assay. J. Clin. Pathol. 1968; 21: 638
   PubMedGoogle Scholar
• Blombäck B., Blombäck M. Purification of bovine and human fibrinogen. Ark. Kemi 1956; 10: 415
   Google Scholar
• Cullen G. E., Van Slyke D. D. Determination of the fibrin, globulin, and albumin nitrogen of blood plasma. J. Biol. Chem. 1920; 41: 587
   Google Scholar
• Gram H. C. Sturdier over fibrinmaengden i menneskets blod og plasma (Disp.), Copenhagen, 1921, described by Bang H. O., Quantitative determination of fibrinogen in plasma - Gram's method modified. Scand. J. Clin. Lab. Invest. 1957; 9: 205
   PubMedGoogle Scholar
• Regoeczi E. Occlusion of plasma proteins by human fibrin: studies using trace-labelled proteins. Br. J. Haematol. 1968; 14: 279
   PubMed Web of Science ®Google Scholar
• Blombäck B. On the properties of fibrinogen and fibrin. Ark. Kemi 1958; 12: 99
   Google Scholar
• Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Scand. J. Clin. Lab. Invest. Suppl. 1955; 14: 7
   Google Scholar
• Astrup T., Brakman P., Nissen U. The estimation of fibrinogen. Scand. J. Clin. Lab. Invest. 1965; 17: 57
   PubMed Web of Science ®Google Scholar
• Green G. S. Determination of nonfibrin protein in fibrin clots by use of I131-labelled protein fractions. Clin. Chem. 1966; 12: 808
   PubMedGoogle Scholar
• Ratnoff O. D., personal communication
   Google Scholar
• Ogston D., Ogston C. M., Bennett N. B. Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb. Diath. Haemorrh. 1966; 16: 32
   PubMedGoogle Scholar
• Ware A. G., Guest M. M., Seegers W. H. Fibrinogen: with special reference to its preparation and certain properties of the products. Arch. Biochem. 1947; 13: 231
   PubMedGoogle Scholar
• Ware A. G., Cannon D. C., Olitzky I., Inkpen J. A. Proteins. Clinical Chemistry: Principles and Technics, 2nd ed., R. J. Henry, D. C. Cannon, J. W. Winkelman. Harper & Row, Hagerstown, Md. 1974; 458, personal communication; as outlined in
   Google Scholar
• Ratnoff O. D., Potts A. M. The accelerating effect of calcium and other cations on the conversion of fibrinogen to fibrin. J. Clin. Invest. 1954; 33: 206
   PubMed Web of Science ®Google Scholar
• Elias T. P., Iyer G. Y. N. Some inhibitors of the fibrinogen-fibrin conversion. Thromb. Diath. Haemorrh. 1967; 18: 499
   PubMedGoogle Scholar
• Farrel G. W., Wolf P. The measurement of fibrinogen and its derivatives. I. Examination of methods of measurement of clottable fibrinogen. Med. Lab. Technol. 1971; 28: 310
   PubMedGoogle Scholar
• Foster L. B., Frings C. S., Hochholzer J. M. Fibrinogen assay during heparin therapy of disseminated intravascular coagulation. Clin. Chem. 1971; 17: 1216
   PubMedGoogle Scholar
• Ratnoff O. D., Pritchard J. A., Colopy J. E. Hemorrhagic states during pregnancy. N. Engl. J. Med. 1955; 253: 63
   PubMed Web of Science ®Google Scholar
• Huseby R. M., Bang N. U. Fibrinogen. Thrombosis and Bleeding Disorders - Theory and Methods, N. U. Bang, F. K. Beller, E. Deutsch, E. F. Mammen. Academic Press, New York 1971; 230
   Google Scholar
• Atencio A. C., Burdick D. C., Reeve E. B. An accurate isotope dilution method for measuring plasma fibrinogen. J. Lab. Clin. Med. 1965; 66: 137
   Web of Science ®Google Scholar
• Schneider C. L. Rapid estimation of plasma fibrinogen concentration and its use as a guide to therapy of intravascular defibrination. Am. J. Obstet. Gynecol. 1952; 64: 141
   PubMed Web of Science ®Google Scholar
• Bowman H. S., Yelito M. B. A method for determining the plasma fibrinogen titer. Am. J. Obstet. Gynecol. 1957; 74: 670
   PubMedGoogle Scholar
• Rosenberg A. A., Peabody R. A. Rapid estimation of fibrinogen in fibrinolytic and nonfibrinolytic states. Clin. Chem. 1972; 18: 666
   PubMedGoogle Scholar
• Ellis B. C., Stransky A. A quick and accurate method for the determination of fibrinogen in plasma. J. Lab. Clin. Med. 1961; 58: 477
   PubMedGoogle Scholar
• Hershgold E. G., Martin B. A rapid, quantitative determination of clottable fibrinogen unaffected by heparin. Am. J. Clin. Pathol. 1975; 63: 231
   PubMedGoogle Scholar
• Saleem A., Krieg A. F., Fretz K. Improved micromethod for plasma fibrinogen unaffected by heparin therapy. Am. J. Clin. Pathol. 1975; 63: 426
   PubMedGoogle Scholar
• Davey F. R., Carrington C. E., Nelson D. A. Comparison of rapid clottable fibrinogen assays. Clin. Chem. 1972; 18: 1360
   PubMedGoogle Scholar
• Burmester H. B. C., Aulton K., Horsfield G. I. Evaluation of a rapid method for the determination of plasma fibrinogen. J. Clin. Pathol. 1970; 23: 43
   PubMed Web of Science ®Google Scholar
• Kalbfleisch J. M., Bird R. M. Cryofibrinogenemia. N. Engl. J. Med. 1960; 263: 881
   PubMedGoogle Scholar
• Lipinski B., Wegrynowicz Z., Budzynski A. Z., Kopec M., Latallo Z. S., Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thromb. Diath. Haemorrh. 1967; 17: 65
   PubMedGoogle Scholar
• Shainoff J. R., Page I. H. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J. Exp. Med. 1962; 116: 687
   PubMed Web of Science ®Google Scholar
• Ritzmann S. E., Levin W. C. A review: cryopathies. Arch. Intern. Med. 1960; 263: 881
   Google Scholar
• McKee P. A., Kalbfleisch J. M., Bird R. M. Incidence and significance of cryofibrinogenemia. J. Lab. Clin. Med. 1963; 61: 203
   Web of Science ®Google Scholar
• Cohn E. J., Strong L. E., Hughes W. L., Jr., Mulford D. J., Ashworth J. N., Melin M., Taylor H. L. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 1946; 68: 459
   PubMed Web of Science ®Google Scholar
• Godal H. C., Abildgaard U., Kierrulf P. Ethanol gelation and fibrin monomers in plasma. Scand. J. Haematol. Suppl. 1971; 13: 189
   PubMedGoogle Scholar
• Breen F. A., Tullis J. L. Ethanol gelation: a rapid screening test for intravascular coagulation. Ann. Intern. Med. 1968; 69: 1197
   PubMed Web of Science ®Google Scholar
• Breen F. A., Tullis J. L. Ethanol gelation test improved. Ann. Intern. Med. 1969; 71: 33
   Google Scholar
• Gerrits W. B. J., Prakke E. M., van der Meer J., Vreeken J. Causes of a negative ethanol gelation test in diffuse intravascular coagulation. Thromb. Diath. Haemorrh. 1974; 31: 299
   PubMedGoogle Scholar
• Gurewich V. Causes of a negative ethanol gelation test in diffuse intravascular coagulation (letter to the editor). Thromb. Diath. Haemorrh. 1974; 32: 243
   PubMedGoogle Scholar
• von Kaulla E., von Kaulla K. N. Detection of hypercoagulability states by a modified ethanol gelation test and its correlation with other coagulation procedures. Am. J. Clin. Pathol. 1974; 61: 810
   PubMedGoogle Scholar
• Stewart G. J. An electron microscope study of ethanol gelation. Scand. J. Haematol. Suppl. 1971; 113: 193
   Google Scholar
• Gurewich V., Hutchinson E. Detection of intravascular coagulation by serial-dilution protamine sulfate test. Ann. Intern. Med. 1971; 75: 895
   PubMed Web of Science ®Google Scholar
• Niewiarowski S., Gurewich V. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J. Lab. Clin. Med. 1971; 77: 665
   PubMedGoogle Scholar
• Gurewich V., Niewiarowski S., Hutchinson E. The detection of fibrin degradation products - application of the serial dilution protamine sulfate (SDPS) test to fibrinolytic therapy. Scand. J. Haematol. Suppl. 1971; 47: 137
   Google Scholar
• Kidder W. R., Logan L. J., Rapaport S. I., Patch M. J. The plasma protamine paracoagulation test: clinical and laboratory evaluation. Am. J. Clin. Pathol. 1972; 58: 675
   PubMedGoogle Scholar
• Fletcher A. P., Alkjaersig N. Blood screening methods for the diagnosis of venous thrombosis, Bethesda Conference on Venous Thromboembolism. Milbank Mem. Fund Q. 1972; 50(Suppl. 2)170
   Google Scholar
• Fletcher A. P., Alkjaersig N., O'Brien J. R., Tulevski V. G. Blood hypercoagulability and thrombosis. Trans. Assoc. Am. Physicians 1971; 83: 159
   Google Scholar
• O'Brien J. R. Diagnosis of venous thrombosis. Progress in Hemostasis and Thrombosis, T. H. Spaet. Grune & Stratton, New York 1974; Vol. 2: 325
   Google Scholar
• Alkjaersig N., Fletcher A., Burstein R. Association between oral contraceptive use and thromboembolism: a new approach to its investigation based on plasma fibrinogen chromatography. Am. J. Obstet. Gynecol. 1975; 122: 199
   PubMed Web of Science ®Google Scholar
• Nossel H. L., Younger L. R., Wilner G. D., Procupez T., Canfield R. E., Butler V. P., Jr. Radioimmunoassay of human fibrinopeptide A. Proc. Natl. Acad. Sci. U.S.A. 1971; 68: 2350
   PubMedGoogle Scholar
• Cronlund M., Hardin J., Burton J., Lee L., Haber E., Bloch K. J. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. J. Clin. Invest. 1976; 58: 142
   PubMed Web of Science ®Google Scholar
• Kockum C. Radioimmunoassay of fibrinopeptide A - clinical applications. Thromb. Res. 1976; 8: 225
   PubMedGoogle Scholar
• Nossel H. L., Ti M., Kaplan K. M., Spanondis K., Soland T., Butler V. P. The generation of fibrinopeptide A in clinical blood samples. J. Clin. Invest. 1976; 58: 1136
   PubMed Web of Science ®Google Scholar
• Bilezikian S. B., Nossel H. L., Butler V. P., Canfield R. E. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J. Clin. Invest. 1975; 56: 438
   PubMedGoogle Scholar
• Kisker C. T., Rush R. Detection of intravascular coagulation. J. Clin. Invest. 1971; 50: 2235
   PubMedGoogle Scholar
• Kisker C. T., Rush R. A specific assay for the detection of intravascular coagulation. J. Clin. Invest. 1970; 49: 51a
   Google Scholar
• Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 1966; 28: 1
   PubMed Web of Science ®Google Scholar
• Erickson C., String T., Stewart D., Cohen R. J. Evaluation of methods for the detection and quantitation of serum fibrin-fibrinogen degradation products. Am. J. Clin. Pathol. 1972; 58: 394
   PubMedGoogle Scholar
• Marder V. J., Matchett M. O., Sherry S. Detection of fibrinogen and fibrin degradation products. Comparison of six techniques using purified products and application in clinical studies. Am. J. Med. 1971; 51: 71
   PubMedGoogle Scholar
• Garvey M. B., Black J. M. The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle. J. Clin. Pathol. 1972; 25: 680
   PubMedGoogle Scholar
• Ellman L., Carvalho A., Colman R. W. The Thrombo-Wellcotest as a screening test for disseminated intravascular coagulation. N. Engl. J. Med. 1973; 288: 633
   PubMedGoogle Scholar
• Carvalho A., Ellman L., Colman R. W. A comparison of the staphylococcal clumping test and an agglutination test for detection of fibrinogen degradation products. Am. J. Clin. Pathol. 1974; 62: 107
   PubMed Web of Science ®Google Scholar
• Allington M. J. The latex flocculation inhibition test for the detection of fibrin(ogen) degradation products. Scand. J. Haematol. Suppl. 1971; 13: 389
   PubMedGoogle Scholar
• Allington M. J. Detection of fibrin(ogen) degradation products by a latex clumping method. Scand. J. Haematol. Suppl. 1971; 13: 115
   PubMedGoogle Scholar
• Mersky C., Johnson A. J., Kleiner C. J. Fibrinogen digestion products in plasma and serum from normal individuals and from patients with fibrinolytic and defibrination syndromes as determined by tanned red cell hemagglutination inhibition immunoassay (TRCHII). Fed. Proc. Fed. Am. Soc. Exp. Biol. 1965; 24: 453
   Google Scholar
• Fox F. J., Jr., Wide L., Killander J., Gemzell C. Determination of fibrinogen and fibrinolysis products in human plasma by an immunochemical method. Scand. J. Clin. Lab. Invest. 1965; 17: 341
   PubMed Web of Science ®Google Scholar
• Murakami M. An immunological method for demonstrating fibrin or fibrinogen degradation products in the circulating blood. Acta Haematol. Jpn. 1965; 28: 341
   PubMedGoogle Scholar
• Mertens B. F., McDuffie F. C., Bowie E. J. W., Owen C. A., Jr. Rapid sensitive method for measuring fibrinogen split-products in human serum. Mayo Clin. Proc. 1969; 44: 114
   PubMedGoogle Scholar
• Mersky C., Lalezari P., Johnson A. J. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc. Soc. Exp. Biol. Med. 1969; 131: 871
   PubMedGoogle Scholar
• Das P. C., Allan A. G. E., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br. Med. J. 1967; 4: 718
   PubMedGoogle Scholar
• Thomas D. P., Niewiarowski S., Myers A. R., Bloch K. J., Colman R. W. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N. Engl. J. Med. 1970; 283: 663
   PubMedGoogle Scholar
• Cole S. K., Clarkson A. R. Menstrual blood loss and fibrin degradation products. Br. Med. J. 1972; 1: 78
   PubMedGoogle Scholar
• Ferguson A. C., Kennedy H., Ank B. J., Sturgeon P., Stiehm E. R. Detection of fibrin degradation products. A comparison of counterimmunoelectrophoresis and two hemagglutination-inhibition methods. Am. J. Clin. Pathol. 1974; 62: 861
   PubMedGoogle Scholar
• Catt K. J., Hirsh J., Castelan D. J., Naill H. D., Tregear G. W. Radioimmunoassay of fibrinogen and its proteolysis products. Thromb. Diath. Haemorrh. 1968; 20: 1
   PubMedGoogle Scholar
• Shaw S. T., Jr. Fibrin and fibrinogen degradation products by radioimmunoassay. Am. J. Clin. Pathol. (Abstr.) 1974; 62: 302
   Google Scholar
• Shaw S. T., Jr., unpublished observations
   Google Scholar
• Plow E. F., Hougie C., Edgington T. S. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J. Immunol. 1971; 107: 1496
   PubMedGoogle Scholar
• Plow E., Edgington T. S. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J. Clin. Invest. 1973; 52: 273
   PubMedGoogle Scholar
• Gordon Y. B., McNeile A. T., Martin M. J., Chard T. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet 1973; 2: 1168
   PubMedGoogle Scholar
• Gordon Y. B., Martin M. J., Landon J., Chard T. The development of radioimmunoassays for fibrinogen degradation products: Fragments D and E. Br. J. Haematol. 1975; 29: 109
   PubMedGoogle Scholar
• Plow E. F., Edgington T. S. A cleavage-associated neoantigen in the E region of fibrinogen. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1973; 32: 835
   Google Scholar
• Allington M. J. Fibrinogen and fibrin degradation products and the clumping of staphylococci by serum. Br. J. Haematol. 1967; 13: 550
   PubMed Web of Science ®Google Scholar
• Lipinski B., Hawiger J., Jeljaszewicz J. Staphylococcal clumping with soluble fibrin monomer complexes. J. Exp. Med. 1967; 126: 979
   PubMed Web of Science ®Google Scholar
• Hawiger J., Niewiarowski S., Gurewich V., Thomas D. P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J. Lab. Clin. Med. 1970; 75: 93
   PubMed Web of Science ®Google Scholar
• Leavelle D. E., Mertens B. F., Bowie E. J. W., Owen C. A., Jr. Staphylococcal clumping on microtiter plates: a rapid, simple method for measuring fibrinogen split products. Am. J. Clin. Pathol. 1971; 55: 452
   PubMedGoogle Scholar
• Latallo Z. S., Teisseyre E. Evaluation of Reptilase-R and thrombin clotting time in the presence of fibrinogen degradation products and heparin. Scand. J. Haematol. Suppl. 1971; 13: 261
   PubMedGoogle Scholar
• Hedner U., Nilsson I. M. Parallel determinations of FDP and fibrin monomers with various methods. Thromb. Diath. Haemorrh. 1972; 28: 268
   PubMedGoogle Scholar
• Farrell G. W., Wolf P. The measurement of fibrinogen and its derivatives. II. Determination of total immunoreactive fibrinogen in the presence of soluble fibrin monomer complexes (cryoprofibrin complexes). Med. Lab. Technol. 1971; 28: 319
   PubMedGoogle Scholar
• Yip M. L. B., Lee S., Sacks H. J. Nonspecificity of the protamine test for disseminated intravascular coagulation. Am. J. Clin. Pathol. 1972; 57: 487
   PubMedGoogle Scholar
• Gurewich V., Hume M., Patrick M. The laboratory diagnosis of venous thromboembolic disease by measurement of fibrinogen/fibrin degradation products and fibrin monomer. Chest 1973; 64: 585
   PubMedGoogle Scholar
• Gallus A. S., Hirsh J., Gent M. Relevance of preoperative and postoperative leg-vein thrombosis. Lancet 1973; 2: 805
   PubMedGoogle Scholar
• Hirsh J., Gallus A. S., Cade J. F. Diagnosis of thrombosis - evaluation of 125I-fibrinogen scanning and blood tests. Thromb. Diath. Haemorrh. 1974; 32: 11
   PubMedGoogle Scholar